Ieq Capital LLC Buys Shares of 43,585 Envista Holdings Corporation $NVST

Key Points

• Ieq Capital LLC has acquired a new stake in Envista Holdings Corporation (NYSE:NVST), purchasing 43,585 shares valued at approximately $752,000 in Q1.
• Envista's shares have recently been the focus of analysts, with several upgrades, including a boost in target prices by firms like Robert W. Baird and Evercore ISI, raising their estimates to between $19.00 and $23.00.
• The company reported a Q2 EPS of $0.26, which exceeded the consensus estimate of $0.24, and has a projected EPS of 1.050-1.15 for FY 2025.

Ieq Capital LLC acquired a new position in Envista Holdings Corporation (NYSE:NVST - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 43,585 shares of the company's stock, valued at approximately $752,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in NVST. Brickwood Asset Management LLP bought a new position in Envista during the 4th quarter valued at $40,037,000. Dimensional Fund Advisors LP raised its holdings in shares of Envista by 24.0% during the first quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company's stock worth $144,760,000 after acquiring an additional 1,625,206 shares in the last quarter. Pzena Investment Management LLC raised its holdings in shares of Envista by 160.7% during the first quarter. Pzena Investment Management LLC now owns 2,294,257 shares of the company's stock worth $39,599,000 after acquiring an additional 1,414,080 shares in the last quarter. Deerfield Management Company L.P. Series C raised its holdings in Envista by 4,949.9% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 1,018,415 shares of the company's stock valued at $19,645,000 after buying an additional 998,248 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in Envista by 288.2% during the fourth quarter. Ameriprise Financial Inc. now owns 1,075,344 shares of the company's stock valued at $20,743,000 after buying an additional 798,366 shares in the last quarter.

Envista Price Performance

Shares of NVST stock traded up $0.51 during trading hours on Friday, hitting $21.29. The company had a trading volume of 1,910,077 shares, compared to its average volume of 1,606,188. Envista Holdings Corporation has a 12 month low of $14.22 and a 12 month high of $23.00. The firm has a market capitalization of $3.54 billion, a price-to-earnings ratio of 66.52, a PEG ratio of 1.14 and a beta of 0.99. The firm's fifty day moving average is $20.44 and its 200 day moving average is $18.56. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.08 and a current ratio of 2.44.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. Envista had a return on equity of 4.84% and a net margin of 2.11%.The company had revenue of $682.10 million for the quarter, compared to analyst estimates of $638.21 million. During the same period in the prior year, the company posted $0.11 EPS. The company's revenue was up 7.7% compared to the same quarter last year. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. On average, sell-side analysts predict that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

Analyst Ratings Changes

NVST has been the topic of several research analyst reports. Piper Sandler raised their price target on Envista from $17.00 to $19.00 and gave the company a "neutral" rating in a research report on Friday, August 1st. Wells Fargo & Company raised their price target on Envista from $17.00 to $19.00 and gave the company an "equal weight" rating in a research report on Friday, August 1st. UBS Group raised their price target on Envista from $18.00 to $22.00 and gave the company a "neutral" rating in a research report on Tuesday, July 29th. Baird R W raised Envista from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, May 27th. Finally, Morgan Stanley raised their price target on Envista from $16.00 to $17.00 and gave the company an "equal weight" rating in a research report on Friday, August 1st. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $20.92.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.